Benichou J, Varinot J, Bossi-Croci R, Bazot M, Sitbon D, Dahan M, Ferrier C, Dabi Y, Touboul C, Lotz J, Darai E
Department of Obstetrics and Gynecology, Tenon University Hospital, Sorbonne University, 4, rue de la Chine, 75020 Paris, France.
Department of Pathology, Pitié-Salpétrière University Hospital, Sorbonne University, 47-83 Bd de l'Hôpital, 75013 Paris, France.
Gynecol Oncol Rep. 2025 Aug 26;61:101932. doi: 10.1016/j.gore.2025.101932. eCollection 2025 Oct.
Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), is an extremely rare and aggressive ovarian cancer affecting young women, typically associated with poor survival. We present three cases of SCCOHT and review the current literature regarding clinical features, diagnosis, management, and survival.
Three patients aged 16, 29, and 39 years were treated for ovarian masses. None presented with hypercalcemia. In case 1, MRI findings mimicked a mucinous cystadenocarcinoma, while the other two cases appeared as benign ovarian tumors. Following initial surgery and histological diagnosis of SCCOHT, all patients received comprehensive radical surgery, multi-agent chemotherapy, radiotherapy, and autologous stem cell transplantation. Two patients remain recurrence-free at 5 and 20 years, while the third has a 10-month follow-up. Genetic testing was performed in two patients, revealing no constitutional mutations in SMARCA4 or related genes.
These cases highlight the difficulty of establishing a preoperative diagnosis of SCCOHT. Unlike previous reports, our data suggest that intensive multimodal therapy can result in favourable outcomes for stage I SCCOHT. Further studies are needed to define optimal treatment strategies.
卵巢高钙血症型小细胞癌(SCCOHT)是一种极其罕见且侵袭性强的卵巢癌,影响年轻女性,通常预后较差。我们报告三例SCCOHT病例,并回顾当前关于其临床特征、诊断、治疗及生存情况的文献。
三名年龄分别为16岁、29岁和39岁的患者因卵巢肿物接受治疗。均未出现高钙血症。病例1的MRI表现类似黏液性囊腺癌,而另外两例表现为良性卵巢肿瘤。在初次手术及SCCOHT组织学诊断后,所有患者均接受了全面根治性手术、多药化疗、放疗及自体干细胞移植。两名患者分别在5年和20年时无复发,第三名患者随访10个月。对两名患者进行了基因检测,未发现SMARCA4或相关基因的胚系突变。
这些病例凸显了术前诊断SCCOHT的困难。与既往报道不同,我们的数据表明,强化多模式治疗可为Ⅰ期SCCOHT带来良好预后。需要进一步研究来确定最佳治疗策略。